In the realm of epidemiology, 3D bioprinting holds the potential to revolutionize how researchers study diseases and develop treatments. This technology can create accurate models of human tissues and organs, allowing for more precise disease modeling and drug testing. This, in turn, can lead to more effective public health strategies and interventions.
